Loading clinical trials...
Loading clinical trials...
Mechanisms, Predictors & Clinical Markers of Dysphagia in Cardiac Surgical Patients_R01
Although dysphagia is a known complication of cardiac surgery, risk factors and sensitive bedside clinical markers of dysphagia have not yet been identified. This longitudinal study will enroll 380 cardiac surgical patients and identify contributing risk factors of incident cases of dysphagia and identify sensitive bedside markers of dysphagia. Statistical modeling will produce two pragmatic clinical tools - a risk prediction model and a beside screening tool to improve care models.
Swallowing impairment and VFMI are common, yet often overlooked, complications of cardiovascular surgical procedures. The true incidence of both dysphagia and VFMI in this patient population is unclear due to a lack of rigorous study using instrumental assessment techniques and validated outcomes in all patients undergoing cardiovascular surgery. The study is therefore aimed to determine the incidence of dysphagia and VFMI in this patient population and to characterize impairment profiles related to swallowing safety and efficiency. In addition, the study is also aimed to assess the relative impact of VFMI and dysphagia on health-related outcomes such as length of hospital stay, pneumonia, sepsis, reintubation, and discharge status. The study will identify risk factors for postoperative dysphagia and VFMI in cardiovascular patients to build a practical electronic risk-stratification tool. The study will also aim to identify sensitive bedside clinical markers of dysphagia in postoperative cardiovascular patients to develop a bedside screening tool. All participants with planned surgeries will undergo two research visits (one preoperatively and one postoperatively) where they will undergo an instrumental swallowing test and complete several patient report outcomes and clinical tests. If they are found to have dysphagia after surgery, they will be offered no-cost follow-up swallow tests at months 1 and 6. For those without planned surgeries, the same course of tests with the exception of the preoperative research visit will be completed. Finally, health-related outcomes will be indexed in enrolled participants to determine the impact of dysphagia.
Age
18 - 90 years
Sex
ALL
Healthy Volunteers
No
University of Florida
Gainesville, Florida, United States
The Ohio State University
Columbus, Ohio, United States
Start Date
June 7, 2022
Primary Completion Date
October 1, 2026
Completion Date
December 31, 2026
Last Updated
October 14, 2025
347
ACTUAL participants
Fiberoptic Endoscopic Evaluation of Swallowing
DIAGNOSTIC_TEST
Simultaneous FEES and Videofluoroscopy instrumental swallowing exam
DIAGNOSTIC_TEST
Videofluoroscopy instrumental swallowing exam (VFSS)
DIAGNOSTIC_TEST
Voluntary Cough Peak Expiratory Flow (PEF) Testing
OTHER
Reflex Cough Screen
OTHER
Lingual Pressure Testing
OTHER
Speech Testing
DIAGNOSTIC_TEST
Lead Sponsor
University of Florida
Collaborators
NCT06909773
NCT06505109
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06189313